Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | FAM171B | Human | 1,2-dichloroethane | decreases expression | ISO | Fam171b (Mus musculus) | 6480464 | ethylene dichloride results in decreased expression of FAM171B mRNA | CTD | PMID:28189721 and PMID:28960355 | FAM171B | Human | 17beta-estradiol | multiple interactions | EXP | | 6480464 | [Estradiol co-treated with Progesterone] results in increased expression of FAM171B mRNA and [Raloxifene Hydrochloride co-treated with Estradiol] results in increased expression of FAM171B mRNA | CTD | PMID:20660070 and PMID:21185374 | FAM171B | Human | 17beta-estradiol | decreases expression | EXP | | 6480464 | Estradiol results in decreased expression of FAM171B mRNA | CTD | PMID:31614463 | FAM171B | Human | 17beta-estradiol | multiple interactions | ISO | Fam171b (Rattus norvegicus) | 6480464 | [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of FAM171B mRNA | CTD | PMID:32741896 | FAM171B | Human | 17beta-estradiol | increases expression | ISO | Fam171b (Mus musculus) | 6480464 | Estradiol results in increased expression of FAM171B mRNA | CTD | PMID:19484750 | FAM171B | Human | 17beta-estradiol 3-benzoate | multiple interactions | ISO | Fam171b (Rattus norvegicus) | 6480464 | [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of FAM171B mRNA | CTD | PMID:32741896 | FAM171B | Human | 2,2',4,4'-Tetrabromodiphenyl ether | affects expression | ISO | Fam171b (Mus musculus) | 6480464 | 2 more ... | CTD | PMID:30294300 | FAM171B | Human | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Fam171b (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of FAM171B mRNA | CTD | PMID:21570461 and PMID:24680724 | FAM171B | Human | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | Fam171b (Rattus norvegicus) | 6480464 | Tetrachlorodibenzodioxin results in increased expression of FAM171B mRNA | CTD | PMID:32109520 | FAM171B | Human | 2-hydroxypropanoic acid | increases expression | EXP | | 6480464 | Lactic Acid results in increased expression of FAM171B mRNA | CTD | PMID:30851411 | FAM171B | Human | 3,3',5-triiodo-L-thyronine | decreases expression | EXP | | 6480464 | Triiodothyronine results in decreased expression of FAM171B mRNA | CTD | PMID:23397585 | FAM171B | Human | 3,4-methylenedioxymethamphetamine | decreases expression | ISO | Fam171b (Mus musculus) | 6480464 | N-Methyl-3 and 4-methylenedioxyamphetamine results in decreased expression of FAM171B mRNA | CTD | PMID:20188158 | FAM171B | Human | 3-isobutyl-1-methyl-7H-xanthine | multiple interactions | EXP | | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of FAM171B mRNA | CTD | PMID:28628672 | FAM171B | Human | aflatoxin B1 | decreases expression | ISO | Fam171b (Mus musculus) | 6480464 | Aflatoxin B1 results in decreased expression of FAM171B mRNA | CTD | PMID:19770486 | FAM171B | Human | aflatoxin B1 | increases methylation | EXP | | 6480464 | Aflatoxin B1 results in increased methylation of FAM171B intron | CTD | PMID:30157460 | FAM171B | Human | aflatoxin B1 | decreases methylation | EXP | | 6480464 | Aflatoxin B1 results in decreased methylation of FAM171B gene | CTD | PMID:27153756 | FAM171B | Human | arsane | affects methylation | EXP | | 6480464 | Arsenic affects the methylation of FAM171B gene | CTD | PMID:25304211 | FAM171B | Human | arsenic atom | affects methylation | EXP | | 6480464 | Arsenic affects the methylation of FAM171B gene | CTD | PMID:25304211 | FAM171B | Human | arsenite(3-) | decreases expression | EXP | | 6480464 | arsenite results in decreased expression of FAM171B mRNA | CTD | PMID:23974009 | FAM171B | Human | benzo[a]pyrene | decreases expression | ISO | Fam171b (Mus musculus) | 6480464 | Benzo(a)pyrene results in decreased expression of FAM171B mRNA | CTD | PMID:19770486 | FAM171B | Human | benzo[a]pyrene | affects methylation | EXP | | 6480464 | Benzo(a)pyrene affects the methylation of FAM171B promoter | CTD | PMID:27901495 | FAM171B | Human | bisphenol A | decreases expression | ISO | Fam171b (Rattus norvegicus) | 6480464 | bisphenol A results in decreased expression of FAM171B mRNA | CTD | PMID:25181051 | FAM171B | Human | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of FAM171B mRNA | CTD | PMID:29275510 | FAM171B | Human | bisphenol A | increases expression | ISO | Fam171b (Rattus norvegicus) | 6480464 | bisphenol A results in increased expression of FAM171B mRNA | CTD | PMID:30816183 | FAM171B | Human | bisphenol F | multiple interactions | EXP | | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of FAM171B mRNA | CTD | PMID:28628672 | FAM171B | Human | cadmium dichloride | decreases expression | EXP | | 6480464 | Cadmium Chloride results in decreased expression of FAM171B mRNA | CTD | PMID:38382870 | FAM171B | Human | cantharidin | increases expression | ISO | Fam171b (Mus musculus) | 6480464 | Cantharidin results in increased expression of FAM171B mRNA | CTD | PMID:36907384 | FAM171B | Human | chlorpyrifos | decreases expression | ISO | Fam171b (Mus musculus) | 6480464 | Chlorpyrifos results in decreased expression of FAM171B mRNA | CTD | PMID:37019170 | FAM171B | Human | cisplatin | multiple interactions | EXP | | 6480464 | [Cisplatin co-treated with jinfukang] results in increased expression of FAM171B mRNA | CTD | PMID:27392435 | FAM171B | Human | cisplatin | increases expression | EXP | | 6480464 | Cisplatin results in increased expression of FAM171B mRNA | CTD | PMID:27392435 | FAM171B | Human | coumestrol | multiple interactions | EXP | | 6480464 | [Coumestrol co-treated with resveratrol] results in decreased expression of FAM171B mRNA | CTD | PMID:19167446 | FAM171B | Human | cyclosporin A | increases expression | EXP | | 6480464 | Cyclosporine results in increased expression of FAM171B mRNA | CTD | PMID:20106945 | FAM171B | Human | DDT | decreases expression | ISO | Fam171b (Rattus norvegicus) | 6480464 | DDT results in decreased expression of FAM171B mRNA | CTD | PMID:30207508 | FAM171B | Human | dexamethasone | multiple interactions | EXP | | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of FAM171B mRNA | CTD | PMID:28628672 | FAM171B | Human | dichloroacetic acid | decreases expression | ISO | Fam171b (Mus musculus) | 6480464 | Dichloroacetic Acid results in decreased expression of FAM171B mRNA | CTD | PMID:28962523 | FAM171B | Human | diuron | decreases expression | ISO | Fam171b (Rattus norvegicus) | 6480464 | Diuron results in decreased expression of FAM171B mRNA | CTD | PMID:25152437 | FAM171B | Human | dorsomorphin | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FAM171B mRNA | CTD | PMID:27188386 | FAM171B | Human | epoxiconazole | decreases expression | ISO | Fam171b (Mus musculus) | 6480464 | epoxiconazole results in decreased expression of FAM171B mRNA | CTD | PMID:35436446 | FAM171B | Human | ethanol | increases expression | ISO | Fam171b (Mus musculus) | 6480464 | Ethanol results in increased expression of FAM171B mRNA | CTD | PMID:30319688 | FAM171B | Human | FR900359 | increases phosphorylation | EXP | | 6480464 | FR900359 results in increased phosphorylation of FAM171B protein | CTD | PMID:37730182 | FAM171B | Human | gentamycin | increases expression | ISO | Fam171b (Rattus norvegicus) | 6480464 | Gentamicins results in increased expression of FAM171B mRNA | CTD | PMID:33387578 | FAM171B | Human | hydrogen peroxide | multiple interactions | EXP | | 6480464 | [Hydrogen Peroxide co-treated with Theophylline] results in increased expression of FAM171B protein | CTD | PMID:18951874 | FAM171B | Human | indometacin | multiple interactions | EXP | | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of FAM171B mRNA | CTD | PMID:28628672 | FAM171B | Human | lead(0) | affects splicing | EXP | | 6480464 | Lead affects the splicing of FAM171B mRNA | CTD | PMID:28903495 | FAM171B | Human | lead(0) | affects expression | EXP | | 6480464 | Lead affects the expression of FAM171B mRNA | CTD | PMID:28903495 | FAM171B | Human | manganese(II) chloride | increases expression | ISO | Fam171b (Rattus norvegicus) | 6480464 | manganese chloride results in increased expression of FAM171B mRNA | CTD | PMID:28801915 | FAM171B | Human | methylisothiazolinone | increases expression | EXP | | 6480464 | 2-methyl-4-isothiazolin-3-one results in increased expression of FAM171B mRNA | CTD | PMID:31629900 | FAM171B | Human | N-methyl-4-phenylpyridinium | decreases expression | EXP | | 6480464 | 1-Methyl-4-phenylpyridinium results in decreased expression of FAM171B mRNA | CTD | PMID:24810058 | FAM171B | Human | N-methyl-4-phenylpyridinium | increases expression | ISO | Fam171b (Rattus norvegicus) | 6480464 | 1-Methyl-4-phenylpyridinium results in increased expression of FAM171B mRNA | CTD | PMID:28801915 | FAM171B | Human | nickel sulfate | increases expression | EXP | | 6480464 | nickel sulfate results in increased expression of FAM171B mRNA | CTD | PMID:22714537 | FAM171B | Human | ozone | multiple interactions | ISO | Fam171b (Mus musculus) | 6480464 | [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of FAM171B mRNA | CTD | PMID:27106289 | FAM171B | Human | paracetamol | increases expression | ISO | Fam171b (Rattus norvegicus) | 6480464 | Acetaminophen results in increased expression of FAM171B mRNA | CTD | PMID:33387578 | FAM171B | Human | pioglitazone | multiple interactions | ISO | Fam171b (Mus musculus) | 6480464 | [N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of FAM171B mRNA | CTD | PMID:27935865 | FAM171B | Human | potassium chromate | increases expression | EXP | | 6480464 | potassium chromate(VI) results in increased expression of FAM171B mRNA | CTD | PMID:22714537 | FAM171B | Human | progesterone | multiple interactions | EXP | | 6480464 | [Estradiol co-treated with Progesterone] results in increased expression of FAM171B mRNA | CTD | PMID:20660070 | FAM171B | Human | propiconazole | decreases expression | ISO | Fam171b (Mus musculus) | 6480464 | propiconazole results in decreased expression of FAM171B mRNA | CTD | PMID:21278054 | FAM171B | Human | rac-lactic acid | increases expression | EXP | | 6480464 | Lactic Acid results in increased expression of FAM171B mRNA | CTD | PMID:30851411 | FAM171B | Human | raloxifene | multiple interactions | EXP | | 6480464 | [Raloxifene Hydrochloride co-treated with Estradiol] results in increased expression of FAM171B mRNA | CTD | PMID:21185374 | FAM171B | Human | resveratrol | multiple interactions | EXP | | 6480464 | [Coumestrol co-treated with resveratrol] results in decreased expression of FAM171B mRNA | CTD | PMID:19167446 | FAM171B | Human | rotenone | decreases expression | EXP | | 6480464 | Rotenone results in decreased expression of FAM171B mRNA | CTD | PMID:29955902 | FAM171B | Human | SB 431542 | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FAM171B mRNA | CTD | PMID:27188386 | FAM171B | Human | sodium arsenite | increases expression | EXP | | 6480464 | sodium arsenite results in increased expression of FAM171B mRNA | CTD | PMID:22714537 and PMID:38568856 | FAM171B | Human | tamoxifen | increases expression | ISO | Fam171b (Mus musculus) | 6480464 | Tamoxifen results in increased expression of FAM171B mRNA | CTD | PMID:25123088 | FAM171B | Human | testosterone | multiple interactions | ISO | Fam171b (Rattus norvegicus) | 6480464 | [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of FAM171B mRNA | CTD | PMID:32741896 | FAM171B | Human | tetrachloromethane | increases expression | ISO | Fam171b (Mus musculus) | 6480464 | Carbon Tetrachloride results in increased expression of FAM171B mRNA | CTD | PMID:27339419 and PMID:31919559 | FAM171B | Human | theophylline | multiple interactions | EXP | | 6480464 | [Hydrogen Peroxide co-treated with Theophylline] results in increased expression of FAM171B protein | CTD | PMID:18951874 | FAM171B | Human | thioacetamide | decreases expression | ISO | Fam171b (Rattus norvegicus) | 6480464 | Thioacetamide results in decreased expression of FAM171B mRNA | CTD | PMID:34492290 | FAM171B | Human | titanium dioxide | decreases expression | ISO | Fam171b (Mus musculus) | 6480464 | titanium dioxide results in decreased expression of FAM171B mRNA | CTD | PMID:29264374 | FAM171B | Human | Tributyltin oxide | increases expression | ISO | Fam171b (Mus musculus) | 6480464 | bis(tri-n-butyltin)oxide results in increased expression of FAM171B mRNA | CTD | PMID:25270620 | FAM171B | Human | trichloroethene | increases expression | ISO | Fam171b (Rattus norvegicus) | 6480464 | Trichloroethylene results in increased expression of FAM171B mRNA | CTD | PMID:33387578 | FAM171B | Human | trichostatin A | decreases expression | EXP | | 6480464 | trichostatin A results in decreased expression of FAM171B mRNA | CTD | PMID:24935251 and PMID:26272509 | FAM171B | Human | trichostatin A | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FAM171B mRNA | CTD | PMID:27188386 | FAM171B | Human | trovafloxacin | decreases expression | ISO | Fam171b (Mus musculus) | 6480464 | trovafloxacin results in decreased expression of FAM171B mRNA | CTD | PMID:35537566 | FAM171B | Human | urethane | increases expression | EXP | | 6480464 | Urethane results in increased expression of FAM171B mRNA | CTD | PMID:28818685 | FAM171B | Human | valproic acid | increases expression | EXP | | 6480464 | Valproic Acid results in increased expression of FAM171B mRNA | CTD | PMID:19101580 more ... | FAM171B | Human | vincristine | decreases expression | EXP | | 6480464 | Vincristine results in decreased expression of FAM171B mRNA | CTD | PMID:23649840 | FAM171B | Human | zoledronic acid | decreases expression | EXP | | 6480464 | zoledronic acid results in decreased expression of FAM171B mRNA | CTD | PMID:24714768 | |